Ahmed Mostafa MD, MSc, PhD, is Director (in training) of ASHI Certified Histocompatibility, Training Program Tissue Typing Laboratory, Department of Pathology, Laboratory Medicine Calgary, Laboratory Services & at University of Calgary. He is a Member of American Society for Histocompatibility and Immunogenetics (ASHI), Canadian Society for Immunology, Beatrice Hunter Cancer Research Institute, European Association of Cancer Research, American Association of Cancer Research, Canadian Society for Life Science Research, Tumor Microenvironment Working Group and American Society of Clinical Oncology.
Author(s): Lianna Li1, Kierra Jones1 and Hao Mei2 1Tougaloo College, USA, 2University of Mississippi, USA
Author(s): Ayse Oner , Z Burcin Gonen, Duygu Gülmez Sevim, Neslihan Sinim, Mustafa Cetin, Yusuf Ozkul Erciyes University, Turkey
Author(s): Nahla El-Eraky El-Azab 1, Abeer M El-Mahalaway1 , Mohamed Abdrabbo 2 , Omar M Said 2 , Dina Sabry3 and Mohamed M El Sibaie 3 1 Benha University, Benha, Egypt 2 Fayoum University, Egypt 3Cairo University, Egypt
Author(s): Darji A1 , Kaushal A1 , Desai N1 and Rajkumar S2 1 Cadila Pharmaceuticals Ltd, India, 2 Nirma University of Science & Technology, India
Author(s): Arshad Ali 1,2,3, Lifang Hu 1,2,3, Airong Qian 1,2,3,Chu Chen 4 and Tuanmin Yang 4 1 Northwestern Polytechnical University, Xi’an, P. R. China 2 Northwestern Polytechnical University, Xi’an, China 3 Northwestern Polytechnical University Xi’an, China 4 Hong-Hui Hospital, Xi’an Jiaotong University College of Medicine, China
Author(s): Vasiliki Androutsopoulou
Author(s): Edona Emini1,2#, Tania Ramos-Moreno1,2#*, Francesca Romana Stefani1,2, Andreas Svensson1,2 and Johan Bengzon 1,2,3 1 Stem Cell Center, BMC B10, Lund University, Lund, Sweden 2 Division of Neurosurgery, Department of Clinical Sciences, Lund University, Lund, Sweden 3 Department of Neurosurgery, Skåne University Hospital, Lund, Sweden # Contributed equally to this work